Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients

Clinical and Experimental Rheumatology

Volumn 29, Issue 5, 2011, Pages 763-767

  Tahoori, M T ^a   Pourfathollah, A A ^a   Akhlaghi, M ^b   Daneshmandi, S ^a   Nicknam, M H ^b   Soleimanifar, N ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DNA purification; Haplotype; PD1.1 A allele; Programmed cell death 1; Promoter; Restriction enzyme; RFLP; Rheumatoid arthritis; Single nucleotide polymorphisms

Indexed keywords

GENOMIC DNA; PROGRAMMED DEATH 1 RECEPTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGRAMMED CELL DEATH 1 RECEPTOR; PROMOTER REGIONS, GENETIC; RISK FACTORS; YOUNG ADULT;

EID: 83455249773     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ABBAS AK, LICHTMAN AH, PILLAI S: Cellular and molecular immunology. Philadelphia Saunders Elsevier, 2007: viii, p. 566
2. NISHIMURA H, OKAZAKI T.TANAKA Y et al:. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291: 319-22. (Pubitemid 32096320)
3. ISHIDA Y, AG ATA Y, SHIB AHAR A K, HONJO T: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 11:3887-95.
4. SHINOHARA T, TANIWAKI M, ISHIDA Y, KAWAICHI M, HONJO T: Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics 1994; 23: 704-6. (Pubitemid 24338661)
5. AGATA Y, KAWASAKI A, NISHIMURA H et al.: Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8: 765-72. (Pubitemid 26148299)
6. FREEMAN GJ, LONG AJ, IWAI Y et al:. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-34.
7. ZHANG X, SCHWARTZ JC, GUO X et al.: Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 2004; 20: 337-47. (Pubitemid 38388235)
8. NISHIMURA H, HONJO T: PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 2001; 22: 265-8. (Pubitemid 32667515)
9. BENNETT F, LUXENBERG D, LING V et al:. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003; 170:711-8. (Pubitemid 36070520)
10. NISHIMURA H. NOSE M, HIAI H, MINATO N, HONJO T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-51. (Pubitemid 29428807)
11. PROKUNINA L, CASTILLEJO-LOPEZ C, OBERG F et al.: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666-9. (Pubitemid 35435182)
12. KONG EK, PROKUNINA-OLSSON L, WONG WH et al.: A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005; 52: 1058-62. (Pubitemid 40530111)
13. NIELSEN C, HANSEN D, HUSBY S, JACOBSEN BB, LILLEVANG ST: Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 2003; 62: 492-7. (Pubitemid 37479307)
14. KRONER A, MEHLING M, HEMMER B et al.: A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005; 58: 50-7. (Pubitemid 40962460)
15. MOSTOWSKA M, WUDARSKI M, CHWALINSKA-SADOWSKA H, JAGODZINSKI PP: The programmed cell death 1 gene 7209 C>T polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population. Clin Exp Rheumatol 2008; 26: 457-60. (Pubitemid 352003216)
16. YANG Q, LIU Y, LIU D, ZHANG Y, MU K: Association of polymorphisms in the programmed cell death I (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population. Clin Exp Rheumatol 2011; 29: 13-18.
17. ARNETT FC, EDWORTHY SM, BLOCH DA et al:. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
18. FRAUWIRTH KA,THOMPSON CB: Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002; 109: 295-9. (Pubitemid 34141801)
19. BOLLAND S, RAVETCH JV: Spontaneous autoimmune disease in Fc(gamma)RIIBdeficient mice results from strain-specific epistasis. Immunity 2000; 13: 277-85.
20. O'KEEFE TL, WILLIAMS GT, DAVIES SL, NEUBERGER MS: Hyperresponsive B cells in CD22-deficient mice. Science 1996; 274: 798-801. (Pubitemid 26398264)
21. WATERHOUSE P, PENNINGER JM, TIMMS E et al.: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270: 985-8.
22. KYOGOKU C, DIJSTELBLOEM HM, TSUCHIYA N et al:. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002; 46: 1242-54. (Pubitemid 34525832)
23. PROKUNINA L, PADYUKOV L, BENNET A et al:. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 2004; 50: 1770-3. (Pubitemid 38725088)